EUVIMEDEUVIMED entdecken
Crossref

1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice

Xiaoning Chen, Jiaofeng Huang, Yanying You, Hanxin Xue, Lisha Wu, Danyi Zeng, Qingqing Xing, Minxia Wu, Mingfang Wang, Jinshui Pan, Su Lin, Yueyong Zhu

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2024.12.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Xiaoning Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China; Department of Hepatology, Hepatology Research Institute, The…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Diet, Western, Pyrazolones, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Approved drugs for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) are limited, although it has become the most common chronic liver disease worldwide. 1-phenyl-3-methyl-5-pyrazolone (PMP) possesses various biological effects such as anti-inflammatory and antioxidant. However, the effects and underlying mechanism of PMP in MASH remain unclear. METHODS: Steatosis cells were induced by palmitate/oleic acid (PO). Then, the contents of lipids and reactive oxygen species were measured. To further investigate the effects of PMP on MASH models, C57BL/6J mice were fed a western diet (WD) for 24 weeks and PMP was administered daily by intragastric gavage. Serum enzymes and lipids were assayed by a biochemistry analyzer. RNA sequencing, real-time qPCR, and western blotting were used to measure the expression of different genes. Histological analysis of the liver included HE, Oil red O, and Sirius red staining. RESULTS: PMP alleviated lipid accumulation and oxidative stress induced by PO (P < 0.001). In vivo, WD-induced significant elevation of blood glucose and serum lipids were reduced by PMP (P < 0.05). Furthermore, PMP effectively prevented hepatic steatosis, inflammation, and fibrosis in MASH mice. Western blot results suggested PMP promoted the phosphorylation of LKB1 and AMPKα at T172, which is a marker of activation of the AMPK pathway. RNA sequencing also demonstrated that PMP facilitated the activation of the AMPK pathway. Furthermore, the protective effects of PMP on steatosis cells and MASH mice disappeared after treatment with an AMPK inhibitor. CONCLUSIONS: PMP protects against metabolic-stress-induced MASH through activating AMPK signaling, indicating that PMP may be a candidate for MASH therapy in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesDiet, WesternPyrazolonesFatty LiverNon-alcoholic Fatty Liver DiseaseAnimalsMiceMice, Inbred C57BLMaleSignal TransductionOxidative StressDisease Models, AnimalLiver

Stichwörter der Autor:innen

1-Phenyl-3-methyl-5-pyrazoloneAMP-Activated protein kinaseEdaravoneMetabolic dysfunction-associated steatohepatitis

Substanzen

AMP-Activated Protein KinasesPyrazolones

Autor:innen und Institutionen

  • Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China; Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian,…
  • Department of Hepatology, Hepatology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China; Fujian Clinical Research Center for Hepatopathy and Intestinal Diseases, China; K…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Huang, J., You, Y., Xue, H., Wu, L., Zeng, D., Xing, Q., Wu, M., Wang, M., Pan, J., Lin, S., & Zhu, Y. (2025). 1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.12.033

Vancouver

Chen X, Huang J, You Y, Xue H, Wu L, Zeng D, et al. 1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2024.12.033

BibTeX
@article{Chen2025,
  author = {Chen, Xiaoning and Huang, Jiaofeng and You, Yanying and Xue, Hanxin and Wu, Lisha and Zeng, Danyi and Xing, Qingqing and Wu, Minxia and Wang, Mingfang and Pan, Jinshui and Lin, Su and Zhu, Yueyong},
  title = {1-phenyl-3-methyl-5-pyrazolone activates the AMPK pathway to alleviate western-diet induced metabolic dysfunction-associated steatohepatitis in mice},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2024.12.033}
}
Kostenlos starten →